Dr Morris on Active Surveillance in Low- and Intermediate-Risk Patients With Prostate Cancer
November 3rd 2023David Morris, MD, FACS, discusses the best practices for active surveillance in low- and intermediate-risk patients with prostate cancer, highlighting factors to look for in patients undergoing active surveillance that may point to the need for further treatment.
Read More